PLoS ONE (Jan 2015)

p31comet-Induced Cell Death Is Mediated by Binding and Inactivation of Mad2.

  • Hyun-Jin Shin,
  • Eun-Ran Park,
  • Sun-Hee Yun,
  • Su-Hyeon Kim,
  • Won-Hee Jung,
  • Seon Rang Woo,
  • Hyun-Yoo Joo,
  • Su Hwa Jang,
  • Hee Yong Chung,
  • Sung Hee Hong,
  • Myung-Haing Cho,
  • Joong-Jean Park,
  • Miyong Yun,
  • Kee-Ho Lee

DOI
https://doi.org/10.1371/journal.pone.0141523
Journal volume & issue
Vol. 10, no. 11
p. e0141523

Abstract

Read online

Mad2, a key component of the spindle checkpoint, is closely associated with chromosomal instability and poor prognosis in cancer. p31comet is a Mad2-interacting protein that serves as a spindle checkpoint silencer at mitosis. In this study, we showed that p31comet-induced apoptosis and senescence occur via counteraction of Mad2 activity. Upon retroviral transduction of p31comet, the majority of human cancer cell lines tested lost the ability to form colonies in a low-density seeding assay. Cancer cells with p31comet overexpression underwent distinct apoptosis and/or senescence, irrespective of p53 status, confirming the cytotoxicity of p31comet. Interestingly, both cytotoxic and Mad2 binding activities were eliminated upon deletion of the C-terminal 30 amino acids of p31comet. Point mutation or deletion of the region affecting Mad2 binding additionally abolished cytotoxic activity. Consistently, wild-type Mad2 interacting with p31comet, but not its non-binding mutant, inhibited cell death, indicating that the mechanism of p31comet-induced cell death involves Mad2 inactivation. Our results clearly suggest that the regions of p31comet affecting interactions with Mad2, including the C-terminus, are essential for induction of cell death. The finding that p31comet-induced cell death is mediated by interactions with Mad2 that lead to its inactivation is potentially applicable in anticancer therapy.